MedTrace Logo

The Effects of Dexmedetomidine on Intravenous Anesthetic Requirements for Children Undergoing Dental Procedures

NCT03422978 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2024-04-22

No results posted yet for this study

Summary

The investigators propose to determine the propofol and remifentanil sparing effects of a single dose of dexmedetomidine in the dental population. The investigators plan to do this by performing a blinded study with 4 test groups (3 experimental and 1 control), using BIS monitoring to titrate TIVA infusion to an acceptable depth of anesthesia.

Conditions

  • Anesthetic Sparing

Interventions

DRUG

Dexmedetomidine

Single dose dexmedetomidine administered over 60 seconds post-induction.

DRUG

Normal saline

Single dose normal saline administered over 60 seconds post-induction.

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Simon Whyte, MBBS, FRCA · BC Children's Hospital, Department of Anesthesia

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
2 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-14
Primary Completion
2021-04-01
Completion
2021-04-01
FDA Drug
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03422978 on ClinicalTrials.gov